ALLISON WASTAK: Open Payments
NPI 1093197923 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 8 payments from 6 companies in 2025. Trend: 2023 $482 · 2024 $980 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Insmed, Inc. | 2 | $38 |
| GENZYME CORPORATION | 1 | $32 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Baxter Healthcare | 1 | $23 |
Products named: DUPIXENT, FASENRA, Arikayce, NUCALA.
Industry payments across CA — which companies pay providers there.
